Clinion is proud to be recognized with the SCDM Innovation Award for Clinical Data Science Implementation Excellence at the SCDM Annual Conference 2024 in Boston.This global recognition highlights our dedication to advancing clinical trial management and setting new standards in data science. It reinforces our leadership in the industry and our unwavering commitment to driving meaningful progress in clinical trials.
Manuj Vangipurapu, Founder & CEO of Clinion, commented on the award: We are honored to receive the SCDM Innovation Award. This recognition reflects our commitment to pushing the boundaries of clinical data management through advanced AI and automation.
Our mission has always been to simplify complex trial processes while ensuring the highest data accuracy and operational efficiency. This award validates our efforts and inspires us to continue delivering solutions that revolutionize the industry.
What makes Clinion Stand Out?
Clinion’s eClinical solutions seamlessly integrate AI and automaation to enhance trial efficiency and accuracy. Some key features that set it apart are:
CDASH Annotation with AI
Clinion’s AI-driven CDASH Annotation simplifies the traditionally manual task of creating annotated Case Report Forms (CRFs). By automating the mapping of study data to CDASH standards, our AI reduces human error and ensures compliance. This automation accelerates the preparation of annotations, making CRFs consistent and compliant with industry standards, and cutting study setup time by 30%.
Gen AI-Powered Data Review: Empowering Data Managers
Clinion’s revolutionary Gen AI-powered data review tool empowers data managers to instantly generate datasets and raise queries, eliminating the dependency on biostatisticians. Using simple English prompts, data managers can create any kind of dataset and then review, and raise queries directly from the datasets. This self-serve capability not only improves data quality but also saves time and reduces manual effort.
Dynamic Reporting with Gen AI: Real-Time Insights
Traditional reporting methods are often slow and complex, hindering timely decision-making. Clinion EDC’s Gen AI technology solves this by enabling data managers to instantly generate custom reports and visualizations. These reports can be saved, scheduled for regular intervals, and shared with stakeholders in real time, enabling faster, more data-driven decision-making.
Explore how our innovative AI solutions earned us the SCDM Award.
Why This Award Matters
This recognition underscores our unwavering commitment to leveraging AI and GenAI technologies to streamline trial processes, ensuring exceptional data accuracy and faster, more accurate outcomes. It not only validates our dedication to continuous innovation but also highlights our efforts in enhancing trial efficiency, reducing timelines, and driving cost savings for our partners. They inspire us to further advance solutions that are transforming the clinical trial landscape.
The Clinion Advantage
30%
faster study setup
60%
faster data review
5X
faster report generation